Detailed View
KYMR - Kymera Therapeutics, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
10,417,100,800
Adj EBIT (TTM)
-350,177,000
Enterprise Value
10,295,040,800
Last Price
126.64
Earnings Yield
-3.40%
Return on Capital
-22.25%
Capital
1,574,118,000
1Y Price Chart
Last Price: $126.64
1Y Change: 187.17%
As of 2026-08-25 | 1Y Change: 187.17%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 65,000,000 | -75,607,000 |
| 2026-03-31 | 10-Q | 2026 | 34,365,000 | -84,154,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 2,871,000 | -97,895,000 |
| 2025-09-30 | 10-Q | 2025 | 2,764,000 | -92,521,000 |
| 2025-06-30 | 10-Q | 2025 | 11,476,000 | -84,557,000 |
| 2025-03-31 | 10-Q | 2025 | 22,100,000 | -74,426,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 7,394,000 | -80,755,000 |
| 2024-09-30 | 10-Q | 2024 | 3,741,000 | -72,124,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.